Publications:

Significant and Durable Clinical Response to Sorafenib and Radiation Therapy for a Patient With Stage IV Hepatocellular Carcinoma and LRRK2 Mutation.

Jco Precision Oncology

Yang, Linlin L; Wald, Patrick P; Roychowdhury, Sameek S; Noonan, Anne M AM; Zuo, Li L; Chuang, Chia-Chen CC; Reeser, Julie J; Wuthrick, Evan E; Schmidt, Carl C; Williams, Terence T

Publication Date: 2019

Variant appearance in text: LRRK2: K1316N

PubMed Link: 32914030

Variant Present in the following documents:

• Main text

View BVdb publication page